Real members of myALZteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice.
Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
The problem with this treatment is that it would cost $56,000 a year!! However, The FDA said the approval of Aduhelm is based on a "surrogate endpoint" that the drug effectively removed amyloid plaque from the brain. Such an endpoint predicts but does not measure whether the drug will slow memory or thinking decline. Are there trials where someone could participate?
myALZteam is not a medical referral site and does not recommend or endorse any particular Provider or medical treatment.
No information on myALZteam should be construed as medical and/or health advice.